Data / Form D filings / Artax Biopharma, Inc.
Artax Biopharma, Inc.: Form D filings
Artax Biopharma, Inc., a pharmaceuticals company in Cambridge, MA, filed 11 Form D notices with the SEC between 2013 and 2026. The latest, on May 5, 2026, reports $19 million sold of a $19 million offering to 30 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- ONE BROADWAY 14TH FLOOR, Cambridge, MA, 02142
- Phone
- (617) 368-0676
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1587661
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 5, 2026 | Amendment | $19,000,000 | $19,000,000 | 30 | Jul 31, 2024 | sec.gov | |
| Jul 29, 2025 | Amendment | $11,000,000 | $11,000,000 | 30 | Jul 31, 2024 | sec.gov | |
| Aug 9, 2024 | New notice | $8,000,000 | $6,000,000 | $2,000,000 | 24 | Jul 31, 2024 | sec.gov |
| May 18, 2022 | Amendment | $25,785,117 | $25,785,117 | 28 | Dec 17, 2021 | sec.gov | |
| Jan 3, 2022 | New notice | $23,182,328 | $12,686,325 | $10,496,003 | 25 | Dec 17, 2021 | sec.gov |
| Feb 26, 2021 | New notice | $3,000,000 | $2,155,015 | $844,985 | 19 | Feb 16, 2021 | sec.gov |
| May 4, 2020 | New notice | $2,000,000 | $2,000,000 | 9 | Apr 17, 2020 | sec.gov | |
| Aug 12, 2019 | New notice | $3,500,000 | $750,000 | $2,750,000 | 24 | Jul 31, 2019 | sec.gov |
| Oct 27, 2015 | New notice | $10,000,000 | $3,000,000 | $7,000,000 | 29 | Jul 29, 2015 | sec.gov |
| Nov 10, 2014 | New notice | $2,007,827 | $2,007,827 | 18 | Jul 17, 2014 | sec.gov | |
| Sep 25, 2013 | New notice | $2,000,000 | $1,268,256 | $731,744 | 19 | Jun 24, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert W. Armstrong, Ph.D. | Executive Officer, Director | |
| Maria Nichol | Executive Officer | |
| Joe Suarez | Executive Officer | |
| Damia Tormo, Ph.D. | Director | |
| Gino Santini | Director | |
| Alan Walts | Director | |
| Casper Breum | Director | |
| Raj Parekh | Director | |
| Andre Hoekema | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of May 4, 2026 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Artax Biopharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.